Cardiovascular Journal of Africa: Vol 23 No 3 (April 2012) - page 70

CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 3, April 2012
e8
AFRICA
plaque, thereby leading to acute STEMI.
3,9,11
Despite divergent
results on STEMI risk in small studies on carriers of the 4G allele
of PAI-1, a large-sized meta-analysis has showed a relationship
between PAI-1 4G/4G and the development of STEMI.
3
Several platelet allo-antigen systems reside on glycoproteins
IIb and IIIa, of which the HPA-1 system is important. However,
there are conflicting data about the relationship between HPA-1
polymorphisms and STEMI.
12,13
HPA1a or HPA-1b phenotypes
may induce platelet aggregation and binding to fibrinogen,
thereby increasing the risk of STEMI.
12
Coronary spasm can lead to acute STEMI with normal
coronary arteries, in association with thrombotic complications,
especially in patients with variant angina. Its ergonovine-
induced prevalence may increase by 20 to 55% in acute
coronary syndromes.
14
We did not provoke coronary spasm with
ergonovine because of its potential risks; however, there was a
catheter-induced spasm in the right coronary artery.
Accordingly, we concluded that coronary spasm was most
likely to have induced the occurrence of acute STEMI in
the presence of a prothrombotic state in our case. However,
it is unclear whether multiple gene polymorphisms without
simultaneous evaluation of their phenotypes may be associated
with arterial thrombotic events.
Conclusion
Multiple gene polymorphisms associated with the prothrombotic
state may contribute to the development of acute STEMI in
adolescents who have a tendency to coronary spasm. Dual
antiplatelet or anticoagulant therapy in addition to a calcium
antagonist may be considered in such patients with recurrent
cardiac events.
References
1.
Kardasz I, de Caterina R. Myocardial infarction with normal coronary
arteries: a conundrum with multiple etiologies and variable prognosis:
an update.
J Int Med
2007;
261
: 330–348.
2.
Yamada Y, Matsuo H, Segawa T,
et al
. Assessment of genetic risk for
myocardial infarction.
Thromb Hemost
2006;
96
: 220–227.
3.
Ye Z, Liu EH, Higgins JP,
et al.
Seven hemostatic gene polymorphisms
in coronary disease: meta-analysis of 66155 cases and 91307 controls.
Lancet
2006;
367
: 651–658.
4.
Inbal A, Freimark D, Modan B,
et al
. Synergistic effects of prothrom-
botic polymorphisms and atherogenic factors on the risk of myocardial
infarction in young males.
Blood
1999;
93
: 2186–2190.
5.
Linenberger ML, Kindelan J, Bennett RL, Reiner AP, Cote HCF.
Fibrinogen Bellingham: A g-chain R275C substitution and a b-promot-
er polymorphism in a thrombotic member of an asymptomatic family.
Am J Hematol
2000;
64
: 242–250.
6.
French JK, Van de Water NS, Sutton TM,
et al
. Potential thrombophilic
mutations/polymorphism in patients with no flow-limiting stenosis after
myocardium infarction.
Am Heart J
2003;
145
: 118–124.
7.
Rallidis LS, Gialeraki A, Komporozos C,
et al
. Role of methylenetet-
rahydrofolate reductase 677C->T polymorphism in the development of
premature myocardial infarction.
Atherosclerosis
2008;
200
: 115–120.
8.
Koestenberger M, Nagel B, Gamillscheg A,
et al.
Myocardial infarction
in an adolescent: anomalous origin of the left main coronary artery fro
the right coronary sinus in association with combined prothrombotic
defects.
Pediatrics
2007;
120
: e424–427.
9.
Picchi A, Pasqualini P, D’Aiello I,
et al.
Acute ST-elevation myocardial
infarction in a 15-year-old boy with celiac disease and multifactorial
thrombotic risk.
Thromb Hemost
2008;
99
: 1116–1118.
10. Meiner V, FriedlanderY, Milo H,
et al.
Cholesteryl ester transfer protein
(CETP) genetic variation and early onset of non-fatal myocardial
infarction.
Ann Human Genetics
2008;
72
: 732–741.
11. Van der Bom JG, Bots ML, Haverkate F, Kluft C, Grobbee DE. The
4G5G polymorphism in the gene for PAI-1 and the circadian oscillation
of plasma PAI-1.
Blood
2003;
101
: 1841–1844.
12. Pontiggia L, Lassila R, Pederiva S,
et al.
Increased platelet-collagen
interaction associated with double homozygosity for receptor poly-
morphisms of platelet GpIa and GpIIIa.
Arterioscler Thromb Vasc Biol
2002;
22
: 2093–2098.
13. Benze G, Heinrich J, Schulte H,
et al.
Association of the GPIa C807T
and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarc-
tion in men.
Eur Heart J
2002;
23
: 325–330.
14. Romagnoli E, Lanza GA. Acute myocardial infarction with normal
coronary arteries: role of coronary artery spasm and arrhythmic compli-
cations.
Int J Cardiol
2007;
117
: 3–5.
1...,60,61,62,63,64,65,66,67,68,69 71,72,73,74,75,76,77,78,79,80,...81
Powered by FlippingBook